55
Views
4
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Recent evidence of sustained benefit with exenatide in Type 2 diabetes

RATNER RE, MAGGS D, NIELSEN LL et al.: Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in overweight metformin-treated patients with type 2 diabetes mellitus. Diabetes Obes. Metab. (2006) 8:419-428 and BLONDE L, KLEIN EJ, HAN J et al.: Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes. Metab. (2006) 8:436-447.

Pages 2003-2006 | Published online: 04 Oct 2006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.